2009 Communication Pharmaceutical Companies 
Eye on FDA
SEPTEMBER 28, 2022
FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. That is particularly true given that the 2009 framework has only been partially addressed by the agency. But for now, we wait.
pharmaphorum
JUNE 14, 2021
In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty pharmaceutical company Advanz Pharma. Graeme discusses his career in the life sciences industry and how Advanz Pharma positions itself as the go-to partner for companies commercialising complex medicines in Europe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Eye on FDA
JANUARY 9, 2022
As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist.
European Pharmaceutical Review
JANUARY 25, 2024
7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceutical companies. Article 63 EMA (29 January 2020).
Eye on FDA
JULY 7, 2020
In the now distant past, enforcement from this office, then called the Division of Drug Marketing, Advertising, and Communications (DDMAC) and later re-named OPDP, was robust, with the office issuing scores of letters a year (156 were issued in 1998). This item disappeared from the agenda, however, and no draft guidance was issued.
pharmaphorum
MARCH 30, 2021
Online communication now seems the natural way to get things done, and the sky’s the limit for what we can achieve for our rare disease patients if we continue to drive this innovation and this openness.”. Connect with Dr Tunnah at [link] or [link].
PharmaState Academy
DECEMBER 18, 2024
Scientific Communication for Pharma Marketing - Quiz Questions: 20 Passing Marks: 80% The number of attempts remaining is 1 Please fill in the required information to participate in the Quiz Competition. a) 60% b) 80% c) 40% d) 30% 6 / 20 What is the impact of personalized scientific communication on HCPs?
Expert insights. Personalized for you.
69 
Let's personalize your content